Anagrelide USP Related Compound A with CAS No: 85325-12-8 is an impurity standard of Anagrelide. Anagrelide, a quinazolinone derivative, inhibits phosphodiesterase activity, particularly phosphodiesterase-III, leading to decreased platelet production in the bone marrow. Its chemical structure, with a quinazolinone core and chlorine substitutions, is crucial for its pharmacological activity. Anagrelide is employed in the treatment of essential thrombocythemia, a condition characterized by elevated platelet levels, by selectively reducing platelet production. Administered orally, it is often considered when other treatments are not well-tolerated, providing a targeted approach to managing platelet counts and mitigating the risk of thrombotic events in affected individuals. Buy high quality Anagrelide USP Related Compound A from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Anagrelide USP Related Compound A
Anagrelide USP Related Compound A
CAT. No.
CP-A76004
CAS. No.
85325-12-8
Mol. F.
C11H14Cl2N2O2 : HCl
Mol. Wt.
277.15 : 36.46
Stock Status
2-3 weeks
Rel. Cas No
70406-92-7(Free Base) ; 85325-12-8 ( XHCl Salt)
Category:
Impurity Standards
Synonyms:
NA
Chemical Name:
Ethyl-2-(6-amino-2,3-dichlorobenzylamino)acetate Hydrochloride
Request for Quotation : Anagrelide USP Related Compound A
Search by Keywords - Buy 85325-12-8 | Purchase 85325-12-8 | Order 85325-12-8 | Enquire 85325-12-8 | Price of 85325-12-8 | 85325-12-8 Cost | 85325-12-8 Supplier | 85325-12-8 Distributor | 85325-12-8 Manufacturer | 85325-12-8 Exporter | Anagrelide USP Related Compound A for Method Validation | Anagrelide USP Related Compound A for ANDA Filing | Anagrelide USP Related Compound A for Forced Degradation Studies | Anagrelide USP Related Compound A Identification Standards | Anagrelide USP Related Compound A for DMF Filing | Anagrelide
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.